| MedChemComm | |
|---|---|
| Abbreviated title (ISO) | MedChemComm |
| Discipline | Chemistry, Medicine |
| Language | English |
| Edited by | Anthony Wood, Greg Verdine |
| Publication details | |
| Publisher | Royal Society of Chemistry (United Kingdom) |
| Publication history | 2010-present |
| Frequency | Monthly |
| Open access | hybrid |
| Indexing | |
| ISSN | 2040-2503 (print) 2040-2511 (web) |
| LCCN | 2011243017 |
| OCLC number | 663378788 |
| Links | |
MedChemComm is a peer-reviewed scientific journal publishing original (primary) research and review articles on all aspects of medicinal chemistry. It is published monthly by the Royal Society of Chemistry. Authors can elect to have accepted articles published as open access.[1]
The editors-in-chief of MedChemComm are Anthony Wood (Pfizer, UK) and Greg Verdine (Harvard University). MedChemComm is the official journal of the European Federation for Medicinal Chemistry (EFMC).
Contents |
MedChemComm publishes articles on all aspects of the medicinal chemistry including drug discovery, pharmacology and pharmaceutical chemistry.
MedChemComm publishes Concise Articles (original scientific work, 3-7 pages in length) and Reviews (critical analyses of specialist areas).[2]